SPARK-BIH Webinar: "Non-dilutive funding every R&D company in Germany can claim"

Discover how Germany’s Forschungszulage can help life-science startups recover R&D personnel costs through non-dilutive funding.

Discover how Germany’s Forschungszulage can help life-science startups recover R&D personnel costs through non-dilutive funding.

Developing a new therapy, diagnostic or medtech product takes years of R&D before any revenue. The Forschungszulage, Germany's R&D tax credit, pays part of that back. It covers up to 42% of your R&D personnel costs every year, with no equity given up. Companies that make no profit yet still get it, paid out as cash.

Join the webinar on November 18 2026, from 12:00 to 13:00 CET.

  • In the first 30 minutes, you will learn how the Forschungszulage works. Arne Wittern, CEO of Coup, will explain who is eligible, which costs can be claimed (including contract research such as CRO studies), how much funding you can expect and how long the process takes.
  • The second half of the webinar will be dedicated to Q&A, so get your questions ready.

Our speaker, Arne Wittern, is Co-Founder and CEO of Coup, which helps startups, scale-ups and established companies secure public funding for their R&D, including Germany's research tax credit (Forschungszulage). Coup has supported more than 300 innovation projects.

As a founder himself, Arne knows first-hand what it takes to turn an idea into a company. He brings practical experience and a founder's perspective on the challenges of building a team and financing early-stage innovation.

Contact us to get the online link spark@bih-charite.de 

 

SPARK-BIH is a member of the SPARK Global network